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Inflammation in the walls of asymptomatic
abdominal aortic aneurysms is not associated with
increased metabolic activity detectable by 18-
fluorodeoxglucose positron-emission tomography
Gustaf Tegler, MD,a Katharina Ericson, MD,b Jens Sörensen, MD, PhD,c Martin Björck, MD, PhD,a and
Anders Wanhainen, MD, PhD,a Uppsala, Sweden
Objective: We hypothesized that the general inflammation observed in the wall of large, asymptomatic abdominal aortic
aneurysms (AAAs) could be detected in vivo by 18-fluorodeoxglucose (FDG) positron-emission tomography (PET) and,
if so, that this method could be used to study if active inflammation is an early pathogenetic finding in small AAAs
detected by screening.
Methods: In this prospective clinical study, 12 men were examined with FDG-PET computed tomography. Seven had large
asymptomatic AAAs (range, 52-66 mm) that required surgery, and five had small AAAs (range, 34-40 mm) under
surveillance. In the surgery group, biopsy specimens were taken from the aneurysm wall for histologic examinations.
Results: Compared with normal segments of the aorta, liver, and blood and compared with healthy controls matched for
age and sex, no increased FDG uptake, measured as standardized uptake value, was detected in any of the large or small
AAAs. The SUVmean difference between infrarenal aorta and blood was 0.3 for cases and 0.1 for controls (P  .06).
The corresponding differences between the infrarenal aorta and liver was0.8 and0.8 (P .91) and between infrarenal
aorta and suprarenal aorta was 0.2 and 0.1 for cases and controls, respectively (P  .20). The histologic examination
of the aneurysm walls showed high inflammatory cell infiltration with T lymphocytes, B lymphocytes, and macrophages.
Conclusions: The chronic inflammation observed in the wall of asymptomatic AAAs was not sufficiently metabolically
active to result in an increased glucose metabolism detectable by FDG-PET by means of this standard protocol. To study
the importance of inflammation in the pathogenesis of AAAs in vivo, PET tracers other than FDG need to be developed.
(J Vasc Surg 2012;56:802-7.)
Clinical Relevance: The etiology of abdominal aortic aneurysms (AAAs) is mostly unknown. Histologic studies have
revealed a chronic inflammation in the media of the aortic wall, and recent studies indicate that this inflammation may be
detectable by means of 18F-fluorodeoxglucose (FDG) positron-emission tomography (PET)/computed tomography
(CT). However, previous reports have predominantly evaluated symptomatic large AAAs, whereas studies on small
asymptomatic AAAs are rare. In this study, we hypothesized that the inflammation observed in the wall of large
asymptomatic AAAs could be detected in vivo by FDG-PET/CT and, if so, that this method could be used to study if
active inflammation is an early pathogenetic finding in small AAAs.
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rAneurysmal dilatation has several known causes, in-
cluding heritable connective tissue disorders1,2 and wall
weakness after infections or arterial dissection, but in90%
of patients with abdominal aortic aneurysms (AAAs), the
etiology of the disease is unknown. One of the most impor-
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802ant features of the arterial wall in aneurysmal disease is the
egradation of the connective tissue. An increased proteo-
ytic activity of elastic lamellae and extracellular matrix
roteins, mainly by matrix metalloproteinase, has been
emonstrated.3,4 A chronic inflammation in the aortic wall
s another characteristic of AAAs, suggesting that immune
esponses play an important role in the pathophysiologic
rocess.5,6
Increased glucose turnover has been related to inflam-
atory activity, and studies on large aneurysms have dem-
nstrated an increased 18-fluorodeoxyglucose (FDG) up-
ake in vivo by means of position-emission tomography
PET)/computed tomography (CT). However, most AAA
tudies have been based on the final stage of the disease,
hen degeneration has already occurred, and the observed
ncreased metabolic activity was predominantly present in
ymptomatic, rapidly expanding, or inflammatory aneu-
ysms.7-10
We hypothesized that the general inflammation ob-
erved in large asymptomatic AAAs could be detected in
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Volume 56, Number 3 Tegler et al 803vivo by FDG-PET/CT and, if so, that this method could be
used to study if active inflammation is an early pathogenic
finding in small AAAs detected by screening. Such a
method could also become of interest as a “proof of prin-
ciple” of pharmacologic treatment of AAAs. The aimwas to
determine if there is an in vivo increased glucose metabo-
lism, detectable with FDG-PET/CT scan, in small AAAs
(range, 30-40 mm) and large asymptomatic AAAs (50
mm) requiring surgery and to study how FDG uptake
correlates to the histologic findings.
METHODS
The Regional Ethics Committee of Uppsala/Örebro
approved the study, and all patients gave oral and written
informed consent. The study included 12men. The surgery
group comprised seven patients with large AAAs scheduled
for open repair (range, 52-66 mm), and the surveillance
group comprised five patients with small AAAs (range,
34-40 mm). All aneurysms were asymptomatic. None of
the patients had any increased growth rate (0.5 mm/6
mo or10mm/1 year). Diabetes and severe cardiopulmo-
nary disease were exclusion criteria because, respectively,
FDG is a glucose analog and severe cardiopulmonary dis-
ease would make the patient unsuitable for open repair.
Baseline characteristics are reported in Table I. There was
no 30-day postoperative mortality in the surgery group.
FDG-PET/CT protocol. All 12 patients underwent
abdominal FDG-PET/CT. The scanner used was a GE
Discovery ST16 (General Electric, Waukesha, Wisc). A
low-dose CT scan without contrast media enhancement
was acquired before the PET scan and used for anatomic
correlation and attenuation correction. The patients fasted
6 hours before tracer injection. PET images were acquired
1 hour after an intravenous injection of 5.0 MBq/kg body
weight of FDG, the recommended dose for whole-body
studies for our scanner type and reconstruction protocol,
issued by the European Association of Nuclear Medicine
(EANM). The scan covered the entire extent of the aorta,
Table I. Baseline characteristic of the 12 study patients
Variablea
Small
AAA
Large
AAA Total
(n  5) (n  7) (N  12)
Age, years 65 (65-66) 67 (65-75) 65 (65-75)
Aneurysm size, mm 36 (34-40) 58 (52-66) 52 (34-66)
Smoking habits
Former 2 4 6
Current 3 3 6
Hypertension 3 5 8
Medication
Acetylsalicylic acid 1 4 5
Statin 0 1 1
Days from PET to
surgery 43 (21-56)
AAA, Abdominal aortic aneurysm; PET, positron-emission tomography.
aContinuous data are expressed as median (range) and categoric data as
number.and images were visually inspected for focal tracer accumu- sations in the aneurysm area and in other vascular struc-
ures.
Regional activity was measured as standardized uptake
alues (SUV)11 normalized for differences in injected dose
nd body weight. SUVmean and SUVmax, the average and
aximum pixel activity within the selected area and vol-
me, were calculated as regional activity (Bq/mL)  body
eight (g)/total injected dose (Bq). Assuming a density of
g/mL, this provides a unitless index of regional activity
ompared with the average of the whole body.
Volumes of interest (VOI) were constructed using the
ig 1. Example of volume of interest placement when appre-
ending the standardized uptake value of the suprarenal (yellow)
nd infrarenal aortic walls (red), in blood (arrow) and in liver (green).
able II. Histologic criteria for grading the
nflammatory infiltrate12, 13
rade Total inflammationa
No inflammation
Sparse scattered chronic inflammatory cells or an
occasional small focus of inflammatory cells
Multiple small foci of inflammatory cells
Multiple large foci of inflammatory cells or a
diffuse, heavy inflammatory cellular infiltrate
rade Macrophage/leukocyte infiltrationb
No macrophages or leukocytes
0-20 cells
21-50 cells
50 cells
Total inflammation calculated on the entire section.
Macrophage/leukocyte infiltration calculated at original magnification 10
n a 1-mm  1-mm square.oftware VOIager 2.0.5, a PET image analysis research tool
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den. VOIs were defined on axial projections of the CT,
where VOIs of the vessel only contained the vessel wall.
VOIs of the aneurysm wall were compared with VOIs of
the suprarenal aorta, blood, and liver (Fig 1).
The control group comprised 13 individuals without
aneurysms who were matched for age and sex with the AAA
patients. They were chosen because they had been clinically
examined with FDG-PET/CT using an identical protocol
as that used for this study.
Histologic protocol. According to the study proto-
col, biopsy specimens were to be taken from the areas with
positive FDG uptake and from the anterior wall of the
aneurysm. If no uptake was detected, a specimen from the
anterior wall alone was to be secured. Samples, including
the full thickness of the anterior aneurysm wall, were col-
lected from the seven patients in the surgery group during
their operations. The samples were immediately fixed in
formaldehyde in the operating theater, processed for his-
tology, and sections were cut and stained.
The total inflammatory load was evaluated on routine
hematoxylin and eosin stained slices. For further categori-
zation and quantification of the inflammation, immunohis-
tochemical stainings were used. Antibodies against lym-
phocytes (CD3), T lymphocytes (CD4 and CD8), B
lymphocytes (CD20), and macrophages and leukocytes
(MAC387) were analyzed in the full thickness of the sample
and in the different wall layers.
The inflammatory infiltrate was analyzed on the entire
section and graded according to the Matthias Bechtel
score12 (Table II), and the cells positive for MAC387 were
calculated using original magnification 10 within 1 mm2
and graded according to a modified macrophage and leu-
kocyte infiltration score13 (Table II).
Statistical analysis. The Wilcoxon signed-rank test
was used to compare SUV values. A value of P  .05 was
considered significant. Statistical evaluation was carried out
with PASW 18 software (IBM Corp, Armonk, NY).
RESULTS
Visual assessment revealed no increased FDG uptake in
the aneurysmwall in any of the 12 patients. No difference in
FDG uptake was observed between small AAAs (range,
34-40 mm) and large AAAs (range, 52-66 mm; P  .47).
The average volumes of the VOIs and number of voxels at
the different locations are reported in Table III and the
Table III. The volumes of interest (VOI) volumes and vo
Location
VOI volume, mean (
Case
Blood 1.0 (0.3-2.1)
Liver 48.1 (18.9-77.7)
Suprarenal aorta 5.5 (3.4-12.7)
Aneurysmal (infrarenal) aorta 10.5 (5.0-16.7)apprehended SUV values in Table IV. Compared with pontrols, AAA patients had slightly lower differences be-
ween infrarenal aortic wall SUVmax and blood or suprare-
al aortic SUVmax, which may imply an increased FDG
ptake in the aneurysmal wall. There were, however, no
ifferences between other regions or when SUVmean was
sed (Table V).
Because no FDG uptake was clearly detectable in the
neurysm walls, biopsy specimens were taken from the
nterior wall of the AAAs in the seven patients who under-
ent surgery. The histologic findings showed a high level
f inflammatory infiltration (total number of inflammatory
ells and number of macrophages and leukocytes) in the
neurysm walls (Table VI). B lymphocytes were predomi-
antly accumulated within the tunica adventitia, T lympho-
ytes in the tunica media and the tunica intima (Fig 2), and
acrophages and leukocytes in the tunica media and tunica
dventitia (Fig 3).
ISCUSSION
In the present study of small and large asymptomatic
AAs, no increased FDG activity was revealed on the visual
r quantitative assessments. Although the histologic find-
ngs showing a high degree of infiltration of both lympho-
ytes and macrophages in the aneurysm wall correspond
ell with previous studies,8,13,14 the observed lack of a high
DG uptake is somewhat contradictory to previous reports.
o examine the possible role of inflammation as an early
vent in the pathogenesis of AAA in vivo, we also decided to
xamine patients with small AAAs. To our knowledge, no
n the VOIs at the different locations
) cm3 Voxels, mean (range) number
Control Case Control
(0.2-1.4) 14 (4-29) 8 (2-18)
(44.0-95.7) 709 (260-1981) 837 (450-1332)
(3.1-7.4) 76 (47-177) 51 (33-76)
(2.0-5.9) 146 (69-233) 40 (28-60)
able IV. Standard uptake values (SUV) different
ocations for abdominal aortic aneurysm (AAA) patients
nd controlsa
ocation SUV
Case Control
Pb(n  12) (n  13)
lood Mean 1.4 (1.4-2.1) 1.3 (0.9-1.6) .005
Max 2.3 (1.8-2.8) 1.6 (1.1-2.0) .001
iver Mean 2.1 (1.8-2.5) 2.0 (1.3-2.6) .27
Max 3.9 (3.3-4.5) 3.0 (2.0-3.9) .001
uprarenal
aorta
Mean 1.6 (1.3-2.2) 1.3 (1.0-1.6) .002
Max 2.8 (2.2-3.5) 2.2 (1.8-2.7) .001
neurysmal
(infrarenal)
aorta
Mean 1.3 (1.1-1.6) 1.2 (0.8-1.4) .073
Max 2.7 (2.4-3.4) 1.8 (1.2-2.3) .001
Values are shown as median (min to max).
Mann-Whitney U test.xels i
range
0.6
65.6
4.1revious report has addressed this issue.
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for AAA studies, and several important differences need to
be addressed. Most previous FDG-PET studies of AAAs
have been performed on large AAAs, including symptom-
atic patients or inflammatory AAAs, or both, whereas stud-
ies on small asymptomatic AAAs are rare. Furthermore,
several previous AAA reports have used SUV , which
Table V. Differences in standard uptake values (SUV) bet
among cases and controlsa
Location SUV
Infrarenal aorta vs blood Mean 
Max
Infrarenal aorta vs liver Mean 
Max 
Infrarenal aorta vs suprarenal aorta Mean 
Max
aValues are shown as median (min to max).
bMann-Whitney U test.
Table VI. Immunohistochemical analysis of the
aneurysmal wall among seven patients operated on for
abdominal aortic aneurysm (AAA)
Pt
Total
inflammation
scorea
Lymphocytesb
Macrophage/leukocyte
infiltrate scorecT (%) B (%)
1 Grade 3 50 50 Grade 3
2 Grade 2 75 25 Grade 3
3 Grade 3 75 25 Grade 3
4 Grade 3 50 50 Grade 3
5 Grade 2 50 50 Grade 2
6 Grade 2 50 50 Grade 2
7 Grade 3 50 50 Grade 3
aEvaluated on routine hematoxylin and eosin-stained slices.
bAntibodies against T lymphocytes (CD4 and CD8) and B lymphocytes
(CD20).
cAntibodies against macrophages/leukocytes (MAC387).
Fig 2. Hematoxylin and eosin–stained aorta shows numerous
inflammatory cells within the tunica media.max
is often used in oncology research.15 In other vascularET studies, such as atherosclerosis research, the use of
UVmean and SUV activity in the blood for calculation of the
issue-to-background ratio are more common.16,17 Other
nvestigators use the SUV activity in the liver as the refer-
nce value.18 These methodologic differences make com-
arisons difficult, and to facilitate comparisons with previ-
us reports, we used various methods in the present study.
● Sakalihasan et al7 described, for the first time in 2002,
an FDG uptake in AAAs with PET/CT scan. This
FDG uptake was, however, predominantly visualized
in aneurysms that were very large (70 mm), symp-
tomatic, inflammatory, or in aneurysms with rapid
expansion.7 Of the 26 investigated AAA patients, 10
showed an increased FDG uptake, of whom only one
had an ordinary asymptomatic AAA. The AAAs with
FDG uptake in the report by Sakalihasan et al7 repre-
sent a subgroup of pathologies with an ongoing pro-
cess, with remodeling associated with a rapid expan-
sion rate or active inflammatory activity, which could
explain the observed high metabolic activity (ie, in-
creased glucose consumption). Interestingly, negative
scans in two patients with inflammatory AAAs were
also reported.
● In a study of 15 patients with large AAAs, Reeps et al8
showed that asymptomatic AAAs had a higher SUV
infrarenal aorta and blood, liver, and suprarenal aorta
Case Control
Pb(n  12) (n  13)
0.9 to 0.1) 0.1 (0.4 to 0.1) .06
0.3 to 1.1) 0.3 (0.4 to 0.5) .04
1.2 to 0.4) 0.8 (1.2 to 0.3) .91
2.1 to 0.6) 1.2 (2.0 to 0.7) .91
0.9 to 0.3) 0.1 (0.5 to 0.1) .2
0.8 to 0.5) 0.4 (0.9 to 0.1) .02
ig 3. Immunohistochemical staining with MAC387 reveals the
acrophages and leukocytes.ween
0.3 (
0.4 (
0.8 (
1.2 (
0.2 (
0.0 (max
compared with the aortas in age-matched control
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September 2012806 Tegler et algroups without AAAs (3.5 vs 3.0; P  .05) and that
symptomatic AAAs had a higher FDG uptake than
asymptomatic AAAs (7.5 vs 3.5; P  .001). The FDG
uptake correlated significantly with the histologic find-
ings of increased numbers of macrophages and T lym-
phocytes.
● In a study of 17 AAA patients, evaluated with FDG-
PET for staging of primary lung cancer, Truijers et al9
showed a higher FDG uptake in the aneurysm wall
compared with the aortic wall of 17 age-matched
controls retrieved from the same database (SUVmax
2.5 vs 0.5; P  .001).
● In a study of 14 AAA patients, of whom two had an
inflammatory AAA, Kotze et al10 showed an increased
FDG uptake in the aneurysm wall in the patients
with inflammatory AAAs. All patients but two had a
SUVmax 2.5.
10
In our material, the SUVmax was2.5 (range, 2.5-4) in
five patients without any visual signs of focal uptake when
the PET scans were scrutinized. When only patients with
asymptomatic AAAs were investigated, the FDG-PET was
most likely to visualize the general inflammation in the
aneurysm wall. This is in contrast to studies of patients with
symptomatic AAAs, where an intense uptake with even
higher inflammatory activity could be an indicator of a
more active remodeling or rupture risk.
We use a standard FDG-PET protocol with a tracer
uptake time (TUT) of 60 minutes, in accordance with
previous PET studies on patients with AAAs.7,9 In recent
vascular FDG-PET imaging, predominantly studying arte-
riosclerosis but also AAAs, TUTs of 908 to 18010 minutes
have been used. A later imaging is supported by a dynamic
study by Rudd et al.19 They found an optimal contrast
between the FDG concentration in plaque and the main
background region (blood) after 190 minutes.19 FDG
uptake in inflammation has, however, been shown to peak
at 60 minutes and decrease thereafter, compared with
cancer, where the uptake may continue to increase for
several hours.20 Thus, although longer imaging may pro-
vide crisper images, the absolute SUV in the tissue would
not increase any further. The observed lack of a difference
in FDG uptake between aneurysmal aortic wall and normal
aortic wall in the present study would therefore most likely
remain even with a prolonged scanning time. Scanning
earlier than one hour would blur the images due to high
blood activity.
In the present study, the FDG uptake in the aneurysm
wall was compared with the uptake in a normal suprarenal
aortic segment. It cannot be ruled out, however, that the
suprarenal nonaneurysmal aorta in a patient with an infra-
renal AAA could be affected by an early stage of aneurysm
disease. Therefore, the activity in blood as well as liver was
also used as a reference. The region of interest was placed so
that only the aortic wall would be considered in the SUV
calculation, which is similar to the method used by Kotze et
al.10 A less defined region of interest could potentially
include other structures, such as lymph nodes, in the cal-ulation of SUV.9 The observed SUV differences between
ases and controls were not limited to the infrarenal aorta.
imilar patterns were found also for blood, liver, and for the
onaneurysmal suprarenal aorta (Table IV). Furthermore,
o differences were observed between cases and controls in
he ratio between SUV from the aneurysmal aorta and SUV
rom reference tissues (Table V). Thus, when adjusted for
he general and slightly higher SUV observed among cases,
o differences remained, indicating no AAA-specific up-
ake.
Differences in patient selection may partly explain the
bserved difference in FDG uptake in the present study
ompared with other studies. Small asymptomatic AAAs
onstitute the vast majority of AAAs, whereas inflammatory
AAs account for 5% of infrarenal AAAs.21-23 The num-
er of patients with an identified asymptomatic AAA will
ncrease as a consequence of AAA screening programs
ecoming widely accepted.24-26
A limitation of the present report is the small sample
ize. However, with none of the 12 asymptomatic AAAs
xamined showing an increased glucose turnover with
DG-PET/CT, it is unlikely that an extended study would
each a different conclusion. Thus, the general chronic
nflammatory infiltrate observed in the wall of asymptom-
tic AAAs is not sufficiently active to result in an increased
lucose metabolism detectable with FDG-PET. It is possi-
le that general inflammation in the wall may have a differ-
nt metabolic activity than “hot spots,” areas with intense
nflammation, indicating areas of aortic wall with risk of
upture, even in asymptomatic AAAs.
ONCLUSIONS
The observed chronic inflammatory infiltrate in the
all of asymptomatic AAAs was not sufficiently metaboli-
ally active to result in an increased glucose metabolism
etectable with FDG-PET by means of this standard pro-
ocol. To study the possible importance of inflammation as
n early event in the pathogenesis of AAAs in vivo, PET
racers other than 18-FDG need to be developed.
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